Progyny, Inc.
PGNY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $2 | $2 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -5.9% | 2.7% | 8.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 23.2% | 23.7% | 23.4% | 21.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 8.1% | 8.5% | 7.8% | 5.6% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 4.4% | 5.1% | 4.6% | 3.5% |
| EPS Diluted | 0.15 | 0.19 | 0.17 | 0.12 |
| % Growth | -21.1% | 11.8% | 41.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |